Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Phase III randomized study of taselisib or placebo with fulvestrant in estrogen receptor-positive, PIK3CA-mutant, HER2-negative, advanced breast cancer: the SANDPIPER trial
Overall, compared with 25 mg of methylcobalamin, a 50 mg twice weekly intramuscular injection is more likely to delay functional decline in patients with early-stage ALS with moderate progression rate
It reduces dark spots and gives a smooth skin tone by lightening away dark spots due to age, sunspots, or acne scars
Apo-A1: (HDL-3 p=4.27E-02
There is no single right answer that applies to everyone at every phase
US$ 29.80
US$ 28.94
US$ 20.96
US$ 29.85
US$ 28.72
US$ 25.86
